国机精工(002046) - 2022 Q3 - 季度财报

Revenue and Profit - Revenue for Q3 2022 was ¥741,314,118.22, a decrease of 12.96% compared to the same period last year[5] - Net profit attributable to shareholders for Q3 2022 was ¥61,723,286.92, an increase of 28.72% year-on-year[5] - Net profit attributable to shareholders after deducting non-recurring gains and losses was ¥50,335,172.78, up 107.58% year-on-year[5] - Total operating revenue for the period reached CNY 2,721,970,276.70, an increase of 8.0% compared to CNY 2,519,525,372.72 in the previous period[18] - Net profit for the period was CNY 200,380,206.74, representing a 12.2% increase from CNY 178,471,734.20 in the same period last year[19] - The company’s total comprehensive income for the period was CNY 200,380,206.74, compared to CNY 178,406,526.35 in the previous period, showing an increase of 12.2%[20] Cash Flow - Cash flow from operating activities for the year-to-date increased by 1,287.28% to ¥76,869,125.95[5] - Cash flow from operating activities was CNY 2,085,973,791.22, compared to CNY 2,001,153,101.09 in the prior period, indicating a growth of 4.2%[22] - The net cash flow from operating activities for Q3 2022 was ¥76,869,125.95, a significant improvement compared to a net outflow of ¥6,474,414.01 in Q3 2021, indicating a positive trend in operational efficiency[23] - Total cash inflow from operating activities reached ¥2,376,590,526.55, up from ¥2,254,102,109.14 in the same period last year, reflecting a growth of approximately 5.4%[23] - Cash outflow for purchasing goods and services was ¥1,585,883,718.62, slightly increased from ¥1,534,724,830.59, showing a rise of about 3.4%[23] - The net cash flow from investing activities was -¥70,745,360.50, an improvement from -¥130,703,746.28 in Q3 2021, indicating better investment management[23] - Cash inflow from financing activities totaled ¥430,801,368.64, compared to ¥564,420,040.72 in the previous year, reflecting a decrease of approximately 23.6%[23] - The net cash flow from financing activities was -¥52,185,788.31, an improvement from -¥190,480,076.09 in Q3 2021, suggesting enhanced financial stability[23] - The ending balance of cash and cash equivalents was ¥501,633,762.55, down from ¥310,137,124.23 in the previous year, indicating a decrease in liquidity[23] - The total cash outflow for investing activities was ¥107,233,648.13, down from ¥309,426,886.73, showing a reduction of approximately 65.3%[23] - The company reported a cash inflow from other investment activities of ¥31,550,000.00, a significant decrease from ¥167,863,530.70 in Q3 2021[23] - The company’s cash flow from operating activities showed resilience despite challenges, with a focus on improving operational cash generation moving forward[23] Assets and Liabilities - Total current assets as of September 30, 2022, amount to ¥3,097,111,756.29, an increase from ¥2,616,930,636.61 at the beginning of the year[16] - Accounts receivable increased significantly to ¥1,101,476,294.68 from ¥617,153,222.34 year-to-date[16] - Inventory as of September 30, 2022, is reported at ¥607,068,882.23, up from ¥530,036,523.95 at the start of the year[16] - Total assets reached ¥5,455,366,569.17, compared to ¥4,925,679,094.36 at the beginning of the year[16] - The total liabilities increased to CNY 2,281,499,141.36, up from CNY 1,910,702,427.98, marking a rise of 19.4%[19] - The total equity attributable to shareholders of the parent company reached CNY 3,048,214,681.70, an increase from CNY 2,884,688,856.13, reflecting a growth of 5.7%[19] Shareholder Information - Total number of common shareholders at the end of the reporting period is 37,102[12] - The largest shareholder, China Machinery Industry Group Co., Ltd., holds 49.60% of shares, totaling 262,452,658 shares[12] - The company has not disclosed any related party relationships among the top shareholders[13] - There are no indications of the top shareholders participating in margin trading activities[13] Research and Development - R&D expenses increased by 60.49% year-on-year, indicating a significant increase in investment in research and development[9] - Research and development expenses rose to CNY 148,340,801.10, a significant increase of 60.6% compared to CNY 92,429,681.35 in the previous period[19] Operating Costs - Total operating costs amounted to CNY 2,472,013,113.81, up 6.5% from CNY 2,320,989,422.43 in the prior period[18] - The company reported a decrease in sales expenses to CNY 35,069,511.08 from CNY 45,968,277.92, a reduction of 23.5%[19]